司库奇尤单抗治疗脓疱型银屑病继发湿疹样皮炎1例

doi:10.35541/cjd.20200652

Chinese Journal of Dermatology ›› 2022, Vol. 55 ›› Issue (10): 903-904.doi: 10.35541/cjd.20200652

• Case Reports • Previous Articles Next Articles

A case of eczematous dermatitis secondary to treatment of pustular psoriasis with secukinumab

Yu Xiaohong, Li Tianbo, Han Shixin, Song Zhiqi

Department of Dermatology, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, Liaoning, China

Received:2020-06-28 Revised:2020-11-02 Online:2022-10-15 Published:2022-10-08
Contact: Yu Xiaohong E-mail:yuxh59@163.com

Abstract

Yu Xiaohong, Li Tianbo, Han Shixin, Song Zhiqi. A case of eczematous dermatitis secondary to treatment of pustular psoriasis with secukinumab[J]. Chinese Journal of Dermatology, 2022, 55(10): 903-904.doi:10.35541/cjd.20200652

References ［9］

［1］	Mugheddu C, Atzori L, Lappi A, et al. Successful secukinumab treatment of generalized pustular psoriasis and erythrodermic psoriasis［J］. J Eur Acad Dermatol Venereol, 2017,31（9）:e420⁃e421. doi: 10.1111/jdv.14234.
［2］	Böhner A, Roenneberg S, Eyerich K, et al. Acute generalized pustular psoriasis treated with the IL⁃17A antibody secukinumab［J］. JAMA Dermatol, 2016,152（4）:482⁃484. doi: 10.1001/jamadermatol. 2015.4686.
［3］	Imafuku S, Honma M, Okubo Y, et al. Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: a 52⁃week analysis from phase III open⁃label multicenter Japanese study［J］. J Dermatol, 2016,43（9）:1011⁃1017. doi: 10.1111/1346⁃8138.13306.
［4］	Al⁃Janabi A, Foulkes AC, Mason K, et al. Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review［J］. J Eur Acad Dermatol Venereol, 2020,34（7）:1440⁃1448. doi: 10.1111/jdv.16246.
［5］	Caldarola G, Pirro F, Di Stefani A, et al. Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL⁃17 treatment: a case series and review of the literature［J］. Expert Opin Biol Ther, 2020,20（6）:665⁃672. doi: 10.1080/14712598.2020.1727439.
［6］	Burlando M, Cozzani E, Russo R, et al. Atopic⁃like dermatitis after secukinumab injection: a case report［J］. Dermatol Ther, 2019,32（1）:e12751. doi: 10.1111/dth.12751.
［7］	Munera⁃Campos M, Ballesca F, Richarz N, et al. Paradoxical eczematous reaction to ixekizumab［J］. J Eur Acad Dermatol Venereol, 2019,33（1）:e40⁃e42. doi: 10.1111/jdv.15156.
［8］	Napolitano M, Megna M, Fabbrocini G, et al. Eczematous eruption during anti⁃interleukin 17 treatment of psoriasis: an emerging condition［J］. Br J Dermatol, 2019,181（3）:604⁃606. doi: 10.1111/bjd.17779.
［9］	Lai F, Higgins E, Smith CH, et al. Morphologic switch from psoriasiform to eczematous dermatitis after anti⁃IL⁃17 therapy: a case series［J］. JAMA Dermatol, 2019,155（9）:1082⁃1084. doi: 10.1001/jamadermatol. 2019.1268.

A case of eczematous dermatitis secondary to treatment of pustular psoriasis with secukinumab

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［9］

Related Articles 0

Metrics

Comments

Recommended 10